Figure 6
Figure 6. Growth factor signaling in mice lacking MC HS. Phospho-PDGFR-β protein expression levels as well as downstream signaling molecules p-Erk1/ 2 and p-SHP-2 are reduced in skin samples of several EXT1MCko, whereas p-Akt signaling is unaffected (A). Comparison of pPDGFR-β levels in skin and CNS of EXT1MCko confirmed that PDGFR-β signaling is unchanged in the CNS of EXT1MCko mice (A) correlating with the observed phenotype; illustration of the percentage of pPDGFR-β normalized to ribosomal protein S6, internal loading control in the skin and brain of protein samples. *P < .05. Control and EXT1MCko; n ≥ 3. Values are mean ± SEM. Immunoprecipitation of VEGFR2 followed by immunoblotting to detect phosphorylated VEGFR2 (B) revealed no differences in pVEGFR2 expression levels in the skin of EXT1MCko; n = 2. Expression studies of pSMAD2 and pSMAD3 molecules by Western blotting, downstream effectors of the TGF-β pathway revealed a significant down regulation in EXT1MCko embryos (C). The reduction in pSMADs is restricted to EXT1MCko skin samples, whereas pSMAD levels in the CNS of mice lacking HS in MCs are unchanged compared with control littermates (C). To access whether reduced pSMAD levels are a result of MC loss in the skin of EXT1MCko embryos, we analyzed pSMAD expression in Pdgfrb null mice lacking MC investment (C). (D) Summarization of densitometric analyses, illustrating the expression levels of pSMAD2 and pSMAD3 normalized to β-tubulin, internal loading control. *P < .05. ns indicates not significant. EXT1MCko and control embryos (n = 4), Pdgfrβ+/− and Pdgfrβ−/− (n = 2). Values are mean ± SEM. Reduced endothelial pSMAD levels could be confirmed by immunohistochemical staining with a pSMAD3 antibody on embryonic skin sections (E-H). Whereas most ECs of blood vessels in control mice are stained positively for pSMAD3 (arrows; E-F), only few ECs in EXT1MCko express pSMAD3 expression (arrows, G-H). Counterstaining with endothelial marker endomucin (red) confirmed endothelial-specific loss of pSMAD3 (green) in EXT1MCko embryos (arrows, G-H), reflecting the reduction of pSMAD3 protein levels in skin (D); n > 3; illustration of different modes of MC recruitment in skin and CNS (I).

Growth factor signaling in mice lacking MC HS. Phospho-PDGFR-β protein expression levels as well as downstream signaling molecules p-Erk1/ 2 and p-SHP-2 are reduced in skin samples of several EXT1MCko, whereas p-Akt signaling is unaffected (A). Comparison of pPDGFR-β levels in skin and CNS of EXT1MCko confirmed that PDGFR-β signaling is unchanged in the CNS of EXT1MCko mice (A) correlating with the observed phenotype; illustration of the percentage of pPDGFR-β normalized to ribosomal protein S6, internal loading control in the skin and brain of protein samples. *P < .05. Control and EXT1MCko; n ≥ 3. Values are mean ± SEM. Immunoprecipitation of VEGFR2 followed by immunoblotting to detect phosphorylated VEGFR2 (B) revealed no differences in pVEGFR2 expression levels in the skin of EXT1MCko; n = 2. Expression studies of pSMAD2 and pSMAD3 molecules by Western blotting, downstream effectors of the TGF-β pathway revealed a significant down regulation in EXT1MCko embryos (C). The reduction in pSMADs is restricted to EXT1MCko skin samples, whereas pSMAD levels in the CNS of mice lacking HS in MCs are unchanged compared with control littermates (C). To access whether reduced pSMAD levels are a result of MC loss in the skin of EXT1MCko embryos, we analyzed pSMAD expression in Pdgfrb null mice lacking MC investment (C). (D) Summarization of densitometric analyses, illustrating the expression levels of pSMAD2 and pSMAD3 normalized to β-tubulin, internal loading control. *P < .05. ns indicates not significant. EXT1MCko and control embryos (n = 4), Pdgfrβ+/− and Pdgfrβ−/− (n = 2). Values are mean ± SEM. Reduced endothelial pSMAD levels could be confirmed by immunohistochemical staining with a pSMAD3 antibody on embryonic skin sections (E-H). Whereas most ECs of blood vessels in control mice are stained positively for pSMAD3 (arrows; E-F), only few ECs in EXT1MCko express pSMAD3 expression (arrows, G-H). Counterstaining with endothelial marker endomucin (red) confirmed endothelial-specific loss of pSMAD3 (green) in EXT1MCko embryos (arrows, G-H), reflecting the reduction of pSMAD3 protein levels in skin (D); n > 3; illustration of different modes of MC recruitment in skin and CNS (I).

Close Modal

or Create an Account

Close Modal
Close Modal